Investival ShowcaseMonday, 16 November 2026 - GMT (Greenwich Mean Time, GMTZ)

Raising your first significant capital is one of the most challenging milestones for early-stage biotech founders. The seed landscape has become increasingly competitive, with investors demanding more data, clearer paths to value inflection, and stronger teams before committing. This panel brings together leading seed-stage VCs to share what it takes to build a compelling story, which investors to target and when, and the common pitfalls that derail promising fundraises. Get direct insights from the investors making funding decisions in today's market

• Building a fundable story: What seed investors need to see in team, science, and strategy

• The data question: How much preclinical validation is enough to close your seed round

• Targeting the right investors and timing your outreach for maximum success

• Common fundraising mistakes that kill momentum and how to avoid them